BB Biotech as of June 30, 2012
Portfolio Holdings for BB Biotech
BB Biotech holds 20 positions in its portfolio as reported in the June 2012 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Celgene Corporation | 16.3 | $175M | 2.7M | 64.16 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 12.1 | $130M | 2.3M | 55.92 | |
Gilead Sciences (GILD) | 10.1 | $108M | 2.1M | 51.28 | |
Incyte Corporation (INCY) | 8.8 | $95M | 4.2M | 22.70 | |
ISIS Pharmaceuticals | 8.2 | $88M | 7.4M | 12.00 | |
ImmunoGen (IMGN) | 5.7 | $61M | 3.7M | 16.74 | |
Amylin Pharmaceuticals | 5.7 | $61M | 2.2M | 28.20 | |
Ariad Pharmaceuticals | 5.0 | $53M | 3.1M | 17.21 | |
Halozyme Therapeutics (HALO) | 4.2 | $45M | 5.1M | 8.86 | |
Alexion Pharmaceuticals | 4.2 | $45M | 450k | 99.30 | |
BioMarin Pharmaceutical (BMRN) | 3.6 | $39M | 976k | 39.58 | |
Medicines Company | 3.4 | $36M | 1.6M | 22.94 | |
Human Genome Sciences | 2.5 | $26M | 2.0M | 13.13 | |
Onyx Pharmaceuticals | 2.2 | $24M | 357k | 66.45 | |
Optimer Pharmaceuticals | 2.1 | $23M | 1.5M | 15.46 | |
Theravance | 1.8 | $19M | 843k | 22.22 | |
Idenix Pharmaceuticals | 1.2 | $13M | 1.3M | 10.28 | |
Dendreon Corporation | 1.1 | $11M | 1.5M | 7.40 | |
Endocyte | 1.0 | $11M | 1.3M | 8.22 | |
Achillion Pharmaceuticals | 0.9 | $9.8M | 1.6M | 6.20 |